Header Logo

Connection

Johnny Mahlangu to Patient Preference

Back to Details
This is a "connection" page, showing publications Johnny Mahlangu has written about Patient Preference.
Johnny Mahlangu
Connection Strength
0,048
Patient Preference
  1. Patient preference for emicizumab versus prior factor therapy in people with haemophilia A: Results from the HAVEN 3 and HAVEN 4 studies. Haemophilia. 2021 Nov; 27(6):e772-e775.
    View in: PubMed
    Score: 0,048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.